Your browser doesn't support javascript.
loading
Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts.
Jiang, Xueyan; Hu, Xiaochen; Daamen, Marcel; Wang, Xiaoqi; Fan, Chunqiu; Meiberth, Dix; Spottke, Annika; Roeske, Sandra; Fliessbach, Klaus; Spruth, Eike Jakob; Altenstein, Slawek; Lohse, Andrea; Hansen, Niels; Glanz, Wenzel; Incesoy, Enise I; Dobisch, Laura; Janowitz, Daniel; Rauchmann, Boris-Stephan; Ramirez, Alfredo; Kilimann, Ingo; Munk, Matthias H; Wang, Xiao; Schneider, Luisa-Sophie; Gabelin, Tatjana; Roy, Nina; Wolfsgruber, Steffen; Kleineidam, Luca; Hetzer, Stefan; Dechent, Peter; Ewers, Michael; Scheffler, Klaus; Amthauer, Holger; Buchert, Ralph; Essler, Markus; Drzezga, Alexander; Rominger, Axel; Krause, Bernd J; Reimold, Matthias; Priller, Josef; Schneider, Anja; Wiltfang, Jens; Buerger, Katharina; Perneczky, Robert; Teipel, Stefan; Laske, Christoph; Peters, Oliver; Düzel, Emrah; Wagner, Michael; Jiang, Jiehui; Jessen, Frank.
Afiliação
  • Jiang X; Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
  • Hu X; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Daamen M; Key Laboratory of Biomedical Engineering of Hainan Province, School of Biomedical Engineering, Hainan University, Haikou, China.
  • Wang X; Department of Psychiatry, University of Cologne, Medical Faculty, Cologne, Germany.
  • Fan C; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Meiberth D; Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
  • Spottke A; Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
  • Roeske S; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Fliessbach K; Department of Psychiatry, University of Cologne, Medical Faculty, Cologne, Germany.
  • Spruth EJ; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Altenstein S; Department of Neurology, University of Bonn, Bonn, Germany.
  • Lohse A; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Hansen N; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Glanz W; University of Bonn Medical Center, Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, Bonn, Germany.
  • Incesoy EI; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Dobisch L; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany.
  • Janowitz D; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Rauchmann BS; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany.
  • Ramirez A; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany.
  • Kilimann I; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.
  • Munk MH; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Wang X; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Schneider LS; Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany.
  • Gabelin T; Department for Psychiatry and Psychotherapy, University Clinic Magdeburg, Magdeburg, Germany.
  • Roy N; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Wolfsgruber S; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
  • Kleineidam L; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Hetzer S; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Dechent P; University of Bonn Medical Center, Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, Bonn, Germany.
  • Ewers M; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Scheffler K; Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
  • Amthauer H; Department of Psychiatry & Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, Texas, USA.
  • Buchert R; German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
  • Essler M; Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.
  • Drzezga A; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
  • Rominger A; Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany.
  • Krause BJ; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin-Institute of Psychiatry and Psychotherapy, Berlin, Germany.
  • Reimold M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin-Institute of Psychiatry and Psychotherapy, Berlin, Germany.
  • Priller J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin-Institute of Psychiatry and Psychotherapy, Berlin, Germany.
  • Schneider A; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Wiltfang J; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Buerger K; University of Bonn Medical Center, Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, Bonn, Germany.
  • Perneczky R; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Teipel S; University of Bonn Medical Center, Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, Bonn, Germany.
  • Laske C; Berlin Center for Advanced Neuroimaging, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Peters O; MR-Research in Neurosciences, Department of Cognitive Neurology, Georg-August-University Goettingen, Goettingen, Germany.
  • Düzel E; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Wagner M; Department for Biomedical Magnetic Resonance, University of Tuebingen, Tuebingen, Germany.
  • Jiang J; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Jessen F; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Alzheimers Dement ; 19(11): 4922-4934, 2023 11.
Article em En | MEDLINE | ID: mdl-37070734
ABSTRACT

INTRODUCTION:

It remains unclear whether functional brain networks are consistently altered in individuals with subjective cognitive decline (SCD) of diverse ethnic and cultural backgrounds and whether the network alterations are associated with an amyloid burden.

METHODS:

Cross-sectional resting-state functional magnetic resonance imaging connectivity (FC) and amyloid-positron emission tomography (PET) data from the Chinese Sino Longitudinal Study on Cognitive Decline and German DZNE Longitudinal Cognitive Impairment and Dementia cohorts were analyzed.

RESULTS:

Limbic FC, particularly hippocampal connectivity with right insula, was consistently higher in SCD than in controls, and correlated with SCD-plus features. Smaller SCD subcohorts with PET showed inconsistent amyloid positivity rates and FC-amyloid associations across cohorts.

DISCUSSION:

Our results suggest an early adaptation of the limbic network in SCD, which may reflect increased awareness of cognitive decline, irrespective of amyloid pathology. Different amyloid positivity rates may indicate a heterogeneous underlying etiology in Eastern and Western SCD cohorts when applying current research criteria. Future studies should identify culture-specific features to enrich preclinical Alzheimer's disease in non-Western populations. HIGHLIGHTS Common limbic hyperconnectivity across Chinese and German subjective cognitive decline (SCD) cohorts was observed. Limbic hyperconnectivity may reflect awareness of cognition, irrespective of amyloid load. Further cross-cultural harmonization of SCD regarding Alzheimer's disease pathology is required.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article